Yale Cancer Center NCTN
Yale Cancer Center NCTN
批准号:
8839216
负责人:
HOWARD S HOCHSTER
金额:
$55.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-16 至 2019-02-28
关键词:
Advanced Malignant NeoplasmAdvocateAllyAntimetabolitesCalendarCancer BiologyCancer CenterCancer HospitalCancer PatientCaringClinicalClinical OncologyClinical ResearchClinical TrialsClinical Trials Cooperative GroupComprehensive Cancer CenterCooperative Group ProgramDermatologyDisciplineDiseaseDoctor of MedicineEnsureFund RaisingFundingGeneral HospitalsGrantGynecologic OncologyHealthHematologyHospitalsInstitutesIntentionLaboratoriesLeadLeadershipMalignant NeoplasmsMassachusettsMedical OncologyMentorsMentorshipNational Clinical Trials NetworkOperations ResearchOperative Surgical ProceduresPersonnel StaffingPharmacologyPhysiciansPositioning AttributePrincipal InvestigatorRadiation OncologyRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResourcesSiteSupervisionSurgeonSystemTimeTrainingTranslational ResearchUnited StatesUniversitiesVisionWarWorkYale Cancer Centerbasecancer pharmacologycancer research center directorcancer therapycareerdrug developmentmedical schoolsmeetingsnext generationprogramsresponsestandard of care
中文摘要
描述(由申请人提供):本申请建议耶鲁大学成为新成立的NCI国家临床试验网络下的网络领先学术参与中心(LAPS)。作为LAPS耶鲁大学将1.在耶鲁大学综合癌症中心(YCC)促进和倡导NCTN临床研究; 2.继续扩大NCTN试验的应计费用,并为YCC会员提供这些重要的国家试验的广泛基础; 3.提供必要的科学领导,以推进NCI资助的NCTN系统研究的事业,并领导重要的试验,以促进癌症治疗和护理标准; 4.为这些NCTN临床试验提供转化科学和实验室支持;培训和指导NCTN小组中的年轻研究人员,并帮助他们提供下一代科学领导力
英文摘要
DESCRIPTION (provided by applicant): This application proposes that Yale University become a Network Lead Academic Participating Site (LAPS) under the newly established NCI National Clinical Trials Network. As an LAPS Yale University will 1. Promote and advocate for NCTN clinical research at the Yale Comprehensive Cancer Center (YCC); 2.continue expanding accrual to NCTN trials and provide broad based access to these important national trials to YCC membership; 3. Provide the scientific leadership necessary in order to advance the cause of NCI funded research in the NCTN system and lead important trials that will advance cancer treatment and standard of care; 4. Provide the translational science and laboratory support for these NCTN clinical trials; 5. Train and mentor Young Investigators in the NCTN groups and help them to provide the next generation of scientific leadership
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLOR
-
批准号:7718426
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CLINICAL TRIAL: ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCE
-
批准号:7718420
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Clinical Trials Office
-
批准号:7714242
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7605733
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7605716
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG N0147: OXAL PLUS 5-FU/CF W/WO CETUXIMAB IN STAGE III COLON CANCERECOG N0
-
批准号:7605775
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7378324
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7378319
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLORECTAL CANCER
-
批准号:7378335
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7378298
-
项目类别:
-
资助金额:$2.95万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:6988335
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
THE FARNESYL TRANSFERASE INHIBITOR R115777 IN COMBINATION WITH TOPOTECAN
-
批准号:7207064
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7207168
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7409167
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
N9831: DOXORUBICIN/CYCLOPHOSPHAMIDE/TAXOL +OR -TRASTUZUMAB FOR BREAST CANCER
-
批准号:7207067
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7089043
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7207141
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7207173
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7226213
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG E3201: PHASE III STUDY IN PATIENTS WITH STAGE II OR III RECTAL CANCER
-
批准号:7207162
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
海外基金